pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Phase 2
spevatamig
spevatamig
Adenocarcinoma Of The Gastroesophageal Junction
Phanes Therapeutics Inc
Phase 2
sugemalimab
Cejemly (sugemalimab [INN])
Natural Killer Cell Lymphomas
CStone Pharmaceuticals Co Ltd
Marketed
sunitinib malate
Sunitinib Malate
Gastrointestinal Stromal Tumor (GIST)
Wanbang Biopharmaceuticals Co Ltd
Marketed
← prev
page 58 of 62
next →
Pain
89
Neurology
1
sunvozertinib
Zegfrovy (sunvozertinib)
Non-Small Cell Lung Cancer
Dizal Pharmaceutical Co Ltd
Phase 2
suratadenoturev
Telomelysin (suratadenoturev)
Adenocarcinoma Of The Gastroesophageal Junction
Oncolys BioPharma Inc
Phase 2
surovatamig
surovatamig [INN]
B-Cell Non-Hodgkin Lymphoma
$AZN
ASTRAZENECA PLC
Phase 2
surufatinib
surufatinib
Solid Tumor
$HCM
HUTCHMED (China) Ltd
Phase 2
surzebiclimab
surzebiclimab
Recurrent Head And Neck Squamous Cell Carcinoma
$ONC
BeOne Medicines Ltd.
Phase 3
tafasitamab
Monjuvi (tafasitamab)
Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associat…
$INCY
INCYTE CORP
Phase 2
tagitanlimab
tagitanlimab [INN]
Nasopharyngeal Cancer
Hbm Holdings Ltd
Phase 2
tagmokitug
tagmokitug
Adenocarcinoma Of The Gastroesophageal Junction
$CHRS
Coherus Oncology, Inc.
Phase 2
tagraxofusp
Elzonris (tagraxofusp-erzs)
Refractory Acute Myeloid Leukemia
Stemline Therapeutics Inc
Marketed
talazoparib tosylate
Talzenna (talazoparib tosylate)
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$PFE
PFIZER INC
Marketed
taletrectinib adipate
Ibtrozi (taletrectinib adipate)
Solid Tumor
$NUVB
Nuvation Bio Inc.
Marketed
talimogene laherparepvec
Imlygic (talimogene laherparepvec)
Metastatic Melanoma
$AMGN
AMGEN INC
Phase 2
tambiciclib
tambiciclib
Diffuse Large B-Cell Lymphoma
$SLS
SELLAS Life Sciences Group, Inc.
Phase 2
tambotatug pelitecan
tambotatug pelitecan
Nasopharyngeal Cancer
F. Hoffmann-La Roche Ltd
Marketed
tamoxifen citrate
Soltamox (tamoxifen citrate)
Breast Cancer
Mayne Pharma USA Inc
Phase 2
tasquinimod
tasquinimod [INN]
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Active Biotech AB
Preclinical
taurolidine
taurolidine [INN]
Neuroblastoma
$CRMD
CorMedix Inc.
Phase 2
tebapivat
tebapivat
Sickle Cell Disease
$AGIO
AGIOS PHARMACEUTICALS, INC.
Marketed
tebentafusp
Kimmtrak (tebentafusp)
Metastatic Uveal Melanoma
$IMCR
Immunocore Holdings plc
Phase 2
tegavivint
tegavivint [INN]
Hepatocellular Carcinoma
Iterion Therapeutics Inc
Phase 2
telisotuzumab adizutecan
telisotuzumab adizutecan [INN]
Gastric Cancer
$ABBV
AbbVie Inc.
Marketed
telisotuzumab vedotin
Emrelis (telisotuzumab vedotin-tllv)
Non-Small Cell Lung Cancer
$ABBV
AbbVie Inc.
Marketed
telotristat ethyl
Xermelo (telotristat ethyl)
Carcinoid Syndrome (Malignant Carcinoid Syndrome)
TerSera Therapeutics LLC
Marketed
temozolomide
Temozolomide
Anaplastic Astrocytoma
Areva Pharmaceuticals Inc
Marketed
temsirolimus
Temsirolimus
Metastatic Renal Cell Carcinoma
Accord Healthcare Inc
Marketed
tepotinib hydrochloride
Tepmetko (tepotinib hydrochloride)
Non-Small Cell Lung Cancer
EMD Serono Inc
Phase 2
testosterone
Testagen TDS (testosterone [INN])
Male Hypogonadism
Transdermal Delivery Solutions Corp
